Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall discussions are very positive and focused on the novelty and importance of zuranolone, with examples like references to FDA approval, phase 3 trial results, and mentions of its rapid action and accessibility, which contribute to high agreement and impact scores. Words like 'breakthrough,' 'significant improvements,' and 'first oral pill' reflect strong enthusiasm and recognition of its potential societal impact.
Most discussions are highly positive, reinforcing the effectiveness and safety of zuranolone, with many emphasizing its approval and potential benefits.
The discussions demonstrate strong interest, as they include detailed trial results, FDA approval news, and calls to learn more about the treatment.
While most discussions highlight interest and impact, some posts are informational or promotional, showing moderate engagement with the topic.
Users recognize zuranolone as a significant breakthrough in postpartum depression treatment, emphasizing its potential to change clinical practice and improve patient lives.
Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishing. This is an exciting finding—if the medication is approved, it could make treatment more accessible for those with severe PPD. https://t.co/Eq8A8aiYLM
New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all time points up to day 45. Adverse events more common in drug group but not very common overall. The only red flag I see is ... 1/2 https://t.co/iTE6qfHEWD https://t.co/RZo5qPCdwe
ACOG’s new Practice Advisory addresses the FDA’s approval of zuranolone, a new oral drug specifically designed to treat symptoms of postpartum depression, a condition that can be debilitating for many patients. See the Practice Advisory: https://t.co/cMLYPTBtkv https://t.co/iZcgwScgdU
New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depression & blues, Dial 14416 (India) https://t.co/zrtnO693Rr
GABA受容体に作用するとされるズラノロンは従来の抗うつ薬よりも即効性があるとされており、産後うつ病の新しい治療につながるかもしれない。 Zuranolone for the Treatment of Postpartum Depression | American Journal of Psychiatry https://t.co/E59aPg5o19
Zuranolone was just approved in postpartum #depression, and the 2nd trial has arrived: Moderate effect size (0.5) that declined slightly (0.3) 4 weeks after the last dose: https://t.co/D2klK2OmrF 2nd trial used 50mg; 1st 30mg; but both had same effect size -@ChrisAikenMD #obgyn https://t.co/Nt9qkWAKG5
In this video, we delve into zuranolone and its revolutionary impact on postpartum depression (PPD) treatment. A phase 3 clinical trial demonstrated its efficacy in significantly reducing depression scores compared to…
This video explores a phase 3 trial study of zuranolone, showing significant improvements in postpartum depression symptoms within 3 days, with safe tolerability in new mothers over a 14-day period. The research…
symptoms were so severe that Jennifer Lawrence sought medical help. As she recounts, she took Zurzuvae: the first oral medication (active ingredient Zuranolone) for the treatment of postpartum depression. The Usa Food and Drug Administration (FDA) approved it in August 2023
GABA系の抗うつ薬？？ Zuranolone for the Treatment of Postpartum Depression - PubMed https://t.co/OzNjZc2Va8
RT @ichiipsy: GABA受容体に作用するとされるズラノロンは従来の抗うつ薬よりも即効性があるとされており、産後うつ病の新しい治療につながるかもしれない。 Zuranolone for the Treatment of Postpartum Depression |…
RT @PsychopharmInst: Zuranolone for the Treatment of Postpartum Depression In this Quick Take, Dr. Vivien Burt discusses the safety and ef…
Mark Your Calendars- March 26 at 12 PM EST, Dr. Muna Said, PharmD, Drug Information Fellow at InpharmD, will be presenting Zuranolone for the treatment of postpartum depression clinical trial. https://t.co/eFeH3DGUBS
The 9/22/2023 #JournalClub presented "Zuranolone for the Treatment of Postpartum Depression." The recording is available free to all AAPP members. https://t.co/m7mrOS4hyZ https://t.co/37jvbwmDwa
Zuranolone for the Treatment of Postpartum Depression: https://t.co/ekJZpDufCK
Discover more episodes from our #podcast, The First Fill! In this episode, we will discuss key counseling points and considerations for the newly FDA-approved zuranolone for the treatment of postpartum depression.
This episode focuses on a major breakthrough in postpartum depression treatment. Dr. Citrome will be in conversation with lead author Dr. Deligiannidis. Monday, October 16, 2023 @ 10:00 AM EST. Register now via the link below. https://t.co/4D6GppvUpy #depression https://t.co/MEgImO4wOZ
RT @APAPubJournals: Zuranolone for the Treatment of Postpartum Depression https://t.co/CTRGK5P3Kf
RT @APAPubJournals: Zuranolone for the Treatment of Postpartum Depression https://t.co/CTRGK5P3Kf
Zuranolone for the Treatment of Postpartum Depression https://t.co/CTRGK5P3Kf
RT @PsychopharmInst: Zuranolone for the Treatment of Postpartum Depression In this Quick Take, Dr. Vivien Burt discusses the safety and ef…
Zuranolone for the Treatment of Postpartum Depression In this Quick Take, Dr. Vivien Burt discusses the safety and efficacy of zuranolone, the first oral allopregnanolone agonist indicated for the treatment of postpartum depression. https://t.co/YPEZLKPqxv #Zuranolone https://t.co/j9bL4aWD0U
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. Read more : https://t.co/BXxd6DwW2P #worldsuicideprevention #suicideprevention #postpartumdepression #PPD #mentalhealthday https://t.co/xOGY5TCJZo
https://t.co/blWO3ZPDZN
RCT: zuranolone 50 mg/day improved depressive symptoms at day 15 vs placebo in severe postpartum depression (LSM-MD HAMD= −4.0; −6.3 to −1.7); improvement in depressive symptoms were reported from day 3. Common AEs: somnolence, dizziness, and sedation https://t.co/YRccdT8qvx
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
RT @acog: ACOG’s new Practice Advisory addresses the FDA’s approval of zuranolone, a new oral drug specifically designed to treat symptoms…
RT @acog: ACOG’s new Practice Advisory addresses the FDA’s approval of zuranolone, a new oral drug specifically designed to treat symptoms…
RT @acog: ACOG’s new Practice Advisory addresses the FDA’s approval of zuranolone, a new oral drug specifically designed to treat symptoms…
ACOG’s new Practice Advisory addresses the FDA’s approval of zuranolone, a new oral drug specifically designed to treat symptoms of postpartum depression, a condition that can be debilitating for many patients. See the Practice Advisory: https://t.co/cMLYPTBtkv https://t.co/iZcgwScgdU
RT @advancedmd: The U.S. Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – m…
The U.S. Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression. https://t.co/iTx2k0MmoI https://t.co/WRx4LVXf7h
Effect of Zuranolone vs Placebo in Postpartum Depression https://t.co/NkGncCSxho Zuranolone for the Treatment of Postpartum Depression | American Journal of Psychiatry https://t.co/EJGb6jfgOX
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression, a serious mental illness that can develop in about 1 in 7 new mothers after childbirth. https://t.co/0M7YEOt6kC
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression, a serious mental illness that can develop in about 1 in 7 new mothers after childbirth. https://t.co/5RKwDGxGxL
We’re excited to share that the American Journal of Psychiatry (@APA_Publishing) published positive findings from our Phase 3 SKYLARK Study with @biogen in #postpartumdepression. Learn more: https://t.co/TeO33T0I29 https://t.co/97TS02Z8KO
This week's highlights: @CVSHealth is planning to open 50 to 60 Oak Street Health clinics in 2024 & @US_FDA has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/Fuh8IgZCZR
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
RT @EikoFried: New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all…
New RCT on an antidepressant for post-partum depression. Reasonable N, & results look pretty clean, with effects across all time points up to day 45. Adverse events more common in drug group but not very common overall. The only red flag I see is ... 1/2 https://t.co/iTE6qfHEWD https://t.co/RZo5qPCdwe
There’s a new FDA-approved drug for people suffering from postpartum depression, which affects an estimated 1 in 8 women with a recent birth. Emily Oster breaks down the data behind the drug: https://t.co/T5iZ2d2HIL Read the latest study on the drug: https://t.co/3hU50Vot64 https://t.co/4BlXCC0Dti
NEW Research: "Zuranolone for the Treatment of Postpartum Depression" Read more about the drug to treat PPD, approved last week by the FDA: https://t.co/d86uYCc9qP
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @chrisaikenmd: Zuranolone was just approved in postpartum #depression, and the 2nd trial has arrived: Moderate effect size (0.5) that de…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression..good to see https://t.co/4N3sF2lI9e
Zuranolone was just approved in postpartum #depression, and the 2nd trial has arrived: Moderate effect size (0.5) that declined slightly (0.3) 4 weeks after the last dose: https://t.co/D2klK2OmrF 2nd trial used 50mg; 1st 30mg; but both had same effect size -@ChrisAikenMD #obgyn https://t.co/Nt9qkWAKG5
Zuranolone was just approved in postpartum #depression. It works quickly (within 3 days) and in this new trial it had a larger benefit than what we see with standard antidepressants https://t.co/q8QAbv6jUm #psychiatry #mentalhealth #maternalhealth https://t.co/hBSOGo7q15
Zuranolone was just approved in postpartum #depression, and the 2nd trial has arrived: Moderate effect size (0.5) that declined slightly (0.3) 4 weeks after the last dose: https://t.co/hvzM6QeNHT 2nd trial used 50mg; 1st used 30mg; both had same effect size #psychiatry #obgyn https://t.co/DOvvEycOJf
RT @6abc: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
FDA approves Zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression, that can develop in about 1 in 7 new mothers after childbirth. https://t.co/UGnT7Pn4l5
RT @ABC30: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for postpartum depression. https://t.co/ykIyEt4MWV https://t.co/COO1AVU3gM
RT @6abc: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/VQJlT8Qvbq
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/gIbDVZDbge
RT @abc13houston: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. h…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/KmogaF4ul4
RT @WmnMentalHealth: New from the CWMH Blog: FDA Approves Zuranolone for the Treatment of Postpartum Depression https://t.co/Zro95GgRtH htt…
RT @6abc: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
The FDA approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the US specifically for postpartum depression, a serious mental illness that can develop in about 1 in 7 new mothers after childbirth. FINALLY
New from the CWMH Blog: FDA Approves Zuranolone for the Treatment of Postpartum Depression https://t.co/Zro95GgRtH https://t.co/0jgcYSeZsL
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
'The FDA approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression,a serious mental illness that can develop in about 1 in 7 new mothers after childbirth.'
RT @ompsychiatrist: New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depressio…
RT @6abc: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/y9SoslH5n9 https://t.co/lzBCAQT68i
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/mhJcdbZE99
RT @ompsychiatrist: New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depressio…
RT @ABC7Chicago: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. ht…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/pEX49fn3qw
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/AUXFhkFxkb
RT @ompsychiatrist: New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depressio…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/hpIgQxUKor
RT @ABC30: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
RT @ompsychiatrist: New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depressio…
RT @ompsychiatrist: New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depressio…
FDA approves first postpartum depression pill in the US: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/cz6nXyI1l4 https://t.co/X6l3UiP3Zk
RT @ompsychiatrist: New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depressio…
RT @ABC7Chicago: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. ht…
RT @ABC30: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/S0rB2yHhpm https://t.co/j0zwfilA3o
RT @ompsychiatrist: New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depressio…
New drug Zuranolone for the Treatment of Postpartum Depression @APA_Publishing To know more about Postpartum Depression & blues, Dial 14416 (India) https://t.co/zrtnO693Rr
RT @ABC7Chicago: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. htt…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/3m71aAQXqC https://t.co/Xd3EnasFLg
The FDA has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the US specifically for postpartum depression https://t.co/EJ8TNOl8Bp
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/eajjDqa6IU
RT @carlos_arnaud: 1 c/7 mujeres desarrollan #DepresionPosparto Nacen en Estados Unidos c/año 400,000 bebés de madres con #Depresión #Zura…
RT @abc13houston: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. h…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/RdGT7Q9M0K
RT @ABC7Chicago: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. ht…
RT @ABC30: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t…
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/mhJcdbZE99
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/AChmSvHAOQ
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/ZgLLVQ0lF7
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression. https://t.co/DHZWLmbPOH
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
Que buen descubrimiento Zuranolona para el tratamiento de la depresión posparto | Revista americana de psiquiatría https://t.co/Dq7tpBInVT
Hi psychopharmacology twitter - thoughts on this new postpartum depression drug? Here’s a recent trial (fast HAM-D decline for drug & placebo) https://t.co/0Y0P0gVC4l https://t.co/bGRWVTLGgL
Zuranolone for the Treatment of Postpartum Depression | American Journal of Psychiatry https://t.co/gtAoYgQkij
RT @carlos_arnaud: 1 c/7 mujeres desarrollan #DepresionPosparto Nacen en Estados Unidos c/año 400,000 bebés de madres con #Depresión #Zura…
RT @carlos_arnaud: 1 c/7 mujeres desarrollan #DepresionPosparto Nacen en Estados Unidos c/año 400,000 bebés de madres con #Depresión #Zura…
1 c/7 mujeres desarrollan #DepresionPosparto Nacen en Estados Unidos c/año 400,000 bebés de madres con #Depresión #Zuranolona es el primer medicamento vía oral específicamente para el tratamiento de la depresión posparto aprobado por @FDA #NeuroEsteroide https://t.co/v0hfS8PYJO https://t.co/DqwPxLQwrx
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
@cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression https://t.co/m2pS9lh0yV
RT @cnni: The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it…
The FDA approved a medication for post-partum depression - a disorder men swear isn't real - and I think that it's about damn time. https://t.co/oL9rHBHeBj
RT @ichiipsy: GABA受容体に作用するとされるズラノロンは従来の抗うつ薬よりも即効性があるとされており、産後うつ病の新しい治療につながるかもしれない。 Zuranolone for the Treatment of Postpartum Depression |…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @ichiipsy: GABA受容体に作用するとされるズラノロンは従来の抗うつ薬よりも即効性があるとされており、産後うつ病の新しい治療につながるかもしれない。 Zuranolone for the Treatment of Postpartum Depression |…
RT @ichiipsy: GABA受容体に作用するとされるズラノロンは従来の抗うつ薬よりも即効性があるとされており、産後うつ病の新しい治療につながるかもしれない。 Zuranolone for the Treatment of Postpartum Depression |…
GABA受容体に作用するとされるズラノロンは従来の抗うつ薬よりも即効性があるとされており、産後うつ病の新しい治療につながるかもしれない。 Zuranolone for the Treatment of Postpartum Depression | American Journal of Psychiatry https://t.co/E59aPg5o19
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
https://t.co/eYtuztbVN8
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
RT @NIMHDirector: Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishin…
Zuranolone, a pill for PPD, led to meaningful improvements in depression symptoms, according to a study in @APA_Publishing. This is an exciting finding—if the medication is approved, it could make treatment more accessible for those with severe PPD. https://t.co/Eq8A8aiYLM
Zuranolone for the Treatment of Postpartum Depression | American Journal of Psychiatry https://t.co/fOphptFRdj
RT @PolicyCenterMMH: Phase III trial data on zuranolone, an oral drug treatment for #postpartumdepression (PPD) were published in the Ameri…
RT @PolicyCenterMMH: Phase III trial data on zuranolone, an oral drug treatment for #postpartumdepression (PPD) were published in the Ameri…
RT @APAPubJournals: Results of a phase 3 trial support the potential of zuranolone as a novel, rapid-acting oral treatment for #postpartum…
RT @APAPubJournals: Results of a phase 3 trial support the potential of zuranolone as a novel, rapid-acting oral treatment for #postpartum…
RT @PolicyCenterMMH: Phase III trial data on zuranolone, an oral drug treatment for #postpartumdepression (PPD) were published in the Ameri…
RT @PolicyCenterMMH: Phase III trial data on zuranolone, an oral drug treatment for #postpartumdepression (PPD) were published in the Ameri…
Phase III trial data on zuranolone, an oral drug treatment for #postpartumdepression (PPD) were published in the American Journal of Psychiatry ; FDA's regulatory decision for the drug is expected next week. https://t.co/nowtsPGYmh
Results of a phase 3 trial support the potential of zuranolone as a novel, rapid-acting oral treatment for #postpartum #depression. @NorthwellHealth https://t.co/fa5DAwbc18 https://t.co/44bvr6Secg
modulation DOI: 10.1176/appi.ajp. 20220785. FIC = first-in-class. Priority, Br = breakthrough, Acc = accelerated approval, FT = fast-track. treatment of ...
doi: 10.1176/appi.ajp. 20220785. Epub 2023 Jul 26. PMID: 37491938. No photo description available.
, Zuranolone for the Treatment of Postpartum. Depression. Am J Psychiatry (doi: 10.1176/appi.ajp.20220785). METHODS. Inclusion Criteria. Patients were included ...
https://doi.org/10.1176/appi.ajp.20220785 • Falah-Hassani, K., Shiri, R., & Dennis, C.-L. (2016). Prevalence and risk factors for comorbid postpartum ...
2023;180(9):668-675. reported receiving grants from NICHD, NIMH, Services Task Force recommendation statement. doi:10.1176/appi.ajp.20220785. Perigee Fund ...
DOI: 10.1176/appi.ajp.20220785. View all 24 comments. Y recuerda: No se automedique, consulte a su médico, es un mensaje de PHARMAMED
... rápida y eficaz, marcando un hito en salud mental materna. DOI: 10.1176/appi.ajp.20220785. more. 3 days ago. quimax2008. •. Follow.
... una opción terapéutica rápida y eficaz, marcando un hito en salud mental materna. DOI: 10.1176/appi.ajp.20220785.".
... una opción terapéutica rápida y eficaz, marcando un hito en salud mental materna. DOI: 10.1176/appi.ajp.20220785.".
DOI: 10.1176/appi.ajp.20220785. more. View all 17 comments. 1 day ago · comunidad_biologica's profile picture · comunidad_biologica. •. Follow.
Zuranolon geht in die Muttermilch über; Effekte auf den Säugling sind bislang nicht bekannt. DOI: 10.1176/appi.ajp.20220785. loading ...
DOI: 10.1176/appi.ajp.20220785. more. View all 5 comments. 5 hours ago · comunidad_biologica's profile picture · comunidad_biologica. •. Follow.
... marcando un hito en salud mental materna. DOI: 10.1176/appi.ajp.20220785. المزيد. عرض جميع التعليقات (16). الآن · comunidad_biologica. •. متابعة.
doi:10.1176/appi.ajp.20220785. 11. Sage-Biogen. Starting Zurzuvae. Zurzuvae for Healthcare Professionals. Accessed June 1, 2024. www ...
doi:10.1176/appi.ajp.20220785. 5. Deligiannidis KM, Meltzer-Brody S, Gunduz-Bruce H, et al. Effect of zuranolone vs placebo in postpartum ...
doi:10.1176/appi.ajp.20220785. 11. Zuranolone for the Treatment of Postpartum Depression. Accessed May 11, 2024. https://www.acog.org ...
DOI: 10.1176/appi.ajp.20220785. View all 24 comments. Y recuerda: No se automedique, consulte a su médico, es un mensaje de PHARMAMED
Zuranolone for the Treatment of Postpartum Depression. Am J Psychiatry. 2023 Sep 1;180(9): 668-675. doi: 10.1176/appi.ajp.20220785. Epub 2023 ...
doi:10.1176/appi.ajp.20220785. Newsletter. Join thousands of clinicians staying current on new therapies, trial data, and expert insights ...
doi:10.1176/appi.ajp.20220785. EXPERT COMMENTARY. Postpartum depression affects approximately 17.2% of patients in the peripartum period.1 ...
2.https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.20220785. 注：本文发布的目的在于传递更多信息，不做任何用药依据，具体用药指引请咨询 ...
2 likes, 0 comments - azueta961 on August 17, 2023: "Disponible en https://doi.org/10.1176/appi.ajp.20220785".
https://doi.org/10.1176/appi.ajp.20220785.
https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.20220785. 3. https://www.nytimes.com/2023/08/04/health/postpartum-depression-pill-fda ...
If you're referring to https://doi.org/10.1176/appi.ajp.20220785 these patients were only treated for 14 days. That is not long term lol.
Quelle: FDA Presseinformation und DOI 10.1176/appi.ajp.20220785 · WhatsApp Kanal Banner. Themenübersicht. drucken; teilen · posten · teilen ...
Published Online:26 Jul 2023https://doi.org/10.1176/appi.ajp.20220785 https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.20220785 · Like.
DOI: 10.1176/appi.ajp.20220785. Journal information: American Journal of Psychiatry. Key medical concepts. Postpartum Depressionzuranolone ...
DOI: 10.1176/appi.ajp.20220785. View all 24 comments. Y recuerda: No se automedique, consulte a su médico, es un mensaje de PHARMAMED
DOI: 10.1176/appi.ajp.20220785. View all 24 comments. Y recuerda: No se automedique, consulte a su médico, es un mensaje de PHARMAMED
DH
EF
A
OM
いバ
CM
AH
B
り
MF
AP
A
IP
AA
QJ
DR
VA
JA
TC
PI
CB
F
P
JG
SM
S
NM
DV
A
DH
SG
DY
EP
ST
FA
RP
AP
CM
EP
MP
DM
P
MI
F
MP
J
M
CP
N
KK
K
AN
D
AA
AC
GG
AH
KP
DE
JK
CH
YS
DF
CG
AF
AE
L
M
OC
BW
DP
C
P
G
AS
PV
RM
KN
TI
EG
D
C
VD
Pป
P
LS
BY
M
SL
TL
LA
L
DA
JP
RS
JM
RO
JH
LM
RI
JK
VN
AZ
M
RC
が
TN
詩
ご
CR
OS
SP
JS
TR
FN
JF
DH
IF
JM
B
S
AL
HL
DY
SO
FW
PH